| Aleksey Mishulin, MD | |
|
5300 Gateway Ctr, Flint, MI 48507-3930 | |
| (810) 720-9111 | |
| (810) 720-9119 |
| Full Name | Aleksey Mishulin |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 9 Years |
| Location | 5300 Gateway Ctr, Flint, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699155366 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 4301107762 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Michigan Vision Institute Pllc | 1658317748 | 5 |
News Archive
Cara Therapeutics, Inc. and Maruishi Pharmaceutical Company, Ltd. today announced that they have entered into a License Agreement providing Maruishi with exclusive rights to develop, manufacture and commercialize Cara's lead analgesic drug candidate, CR845, for acute pain and uremic pruritus in Japan.
A new study from Lund University in Sweden has opened the way for new approaches to slowing the development of AIDS in HIV-1-infected patients. It is hoped that this could lead to better treatment methods and preventive measures to combat HIV and AIDS.
Increased vascular stiffness has been identified as an important part of hypertension in aging adults. Previous studies of aortic stiffness have focused on changes in structural proteins that alter the properties of vascular walls causing them to become rigid.
The cancellation last fall of a Merck HIV/AIDS vaccine trial was "branded as a 'catastrophe' by one scientist and as setting the race for a cure 'back to square one' by others," a Washington Post editorial says, adding, "The hyperbole is understandable, but some perspective is in order."
› Verified 8 days ago
| Entity Name | Michigan Vision Institute Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780746081 PECOS PAC ID: 1658317748 Enrollment ID: O20050629000285 |
News Archive
Cara Therapeutics, Inc. and Maruishi Pharmaceutical Company, Ltd. today announced that they have entered into a License Agreement providing Maruishi with exclusive rights to develop, manufacture and commercialize Cara's lead analgesic drug candidate, CR845, for acute pain and uremic pruritus in Japan.
A new study from Lund University in Sweden has opened the way for new approaches to slowing the development of AIDS in HIV-1-infected patients. It is hoped that this could lead to better treatment methods and preventive measures to combat HIV and AIDS.
Increased vascular stiffness has been identified as an important part of hypertension in aging adults. Previous studies of aortic stiffness have focused on changes in structural proteins that alter the properties of vascular walls causing them to become rigid.
The cancellation last fall of a Merck HIV/AIDS vaccine trial was "branded as a 'catastrophe' by one scientist and as setting the race for a cure 'back to square one' by others," a Washington Post editorial says, adding, "The hyperbole is understandable, but some perspective is in order."
› Verified 8 days ago
| Entity Name | Grosinger Spigelman & Grey Eye Surgeons Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699798660 PECOS PAC ID: 4385672880 Enrollment ID: O20050727000073 |
News Archive
Cara Therapeutics, Inc. and Maruishi Pharmaceutical Company, Ltd. today announced that they have entered into a License Agreement providing Maruishi with exclusive rights to develop, manufacture and commercialize Cara's lead analgesic drug candidate, CR845, for acute pain and uremic pruritus in Japan.
A new study from Lund University in Sweden has opened the way for new approaches to slowing the development of AIDS in HIV-1-infected patients. It is hoped that this could lead to better treatment methods and preventive measures to combat HIV and AIDS.
Increased vascular stiffness has been identified as an important part of hypertension in aging adults. Previous studies of aortic stiffness have focused on changes in structural proteins that alter the properties of vascular walls causing them to become rigid.
The cancellation last fall of a Merck HIV/AIDS vaccine trial was "branded as a 'catastrophe' by one scientist and as setting the race for a cure 'back to square one' by others," a Washington Post editorial says, adding, "The hyperbole is understandable, but some perspective is in order."
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aleksey Mishulin, MD 1750 S Telegraph Ste 205, Bloomfield Hills, MI 48302 Ph: (248) 333-2900 | Aleksey Mishulin, MD 5300 Gateway Ctr, Flint, MI 48507-3930 Ph: (810) 720-9111 |
News Archive
Cara Therapeutics, Inc. and Maruishi Pharmaceutical Company, Ltd. today announced that they have entered into a License Agreement providing Maruishi with exclusive rights to develop, manufacture and commercialize Cara's lead analgesic drug candidate, CR845, for acute pain and uremic pruritus in Japan.
A new study from Lund University in Sweden has opened the way for new approaches to slowing the development of AIDS in HIV-1-infected patients. It is hoped that this could lead to better treatment methods and preventive measures to combat HIV and AIDS.
Increased vascular stiffness has been identified as an important part of hypertension in aging adults. Previous studies of aortic stiffness have focused on changes in structural proteins that alter the properties of vascular walls causing them to become rigid.
The cancellation last fall of a Merck HIV/AIDS vaccine trial was "branded as a 'catastrophe' by one scientist and as setting the race for a cure 'back to square one' by others," a Washington Post editorial says, adding, "The hyperbole is understandable, but some perspective is in order."
› Verified 8 days ago
Dr. Steven Allen Boskovich, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1290 S Linden Rd, Flint, MI 48532 Phone: 810-732-6231 Fax: 810-732-0725 | |
Dr. Aman Khaled Shukairy, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1160 S Linden Rd, Flint, MI 48532 Phone: 810-820-8230 Fax: 810-820-8937 | |
Dr. David A Diskin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4499 Town Center Pkwy, Flint, MI 48532 Phone: 810-733-7111 Fax: 810-733-7141 | |
John A Waters, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5055 W Bristol Rd, Flint, MI 48507 Phone: 810-732-2272 Fax: 810-732-8470 | |
Dr. Jeffrey A Diskin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4499 Town Center Pkwy, Flint, MI 48532 Phone: 810-733-7111 Fax: 810-733-7141 | |
Dr. Gary M Keoleian, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4499 Town Center Pkwy, Flint, MI 48532 Phone: 810-733-7111 Fax: 810-733-7141 | |
Daniel Joseph Ryan, MD Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1113 Villa Linde Ct, Flint, MI 48532 Phone: 810-733-1214 Fax: 810-733-3011 |